Subhash V Kapre

This inventor holds 27 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent, primarily in Vaccine Development. Top assignees: Inventprise, LLC, Serum Institute of India Pvt Ltd.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Subhash V Kapre. Retrieved from https://idiyas.com/inventor/subhash-v-kapre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 14)

% Patents Active = 96.3

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 32(Granted Patents)

Location History:

Bellevue, WA (US) (2017 - 2018)
Redmond, WA (US) (2016 - 2024)

Company Filing History:

Serum Institute of India Pvt Ltd.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Vaccine Compositions

Glycoconjugate Vaccines

Virus-Like Particles

Bioprocess Systems

Polysaccharide Conjugates

Immunogenicity

Heat Stable Vaccines

Adjuvant Formulations

Polysaccharide Purification

Bordetella Pertussis

Point of Use Mixing

Multivalent Vaccines

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734229 - Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F (2026-09-15),

2. 12383682 - Double chamber device for point of use mixing (2025-08-12),

3. 12318440 - VLP stabilized vaccine compositions (2025-06-03),

4. 12251438 - Immunogenic compositions of polysaccharide-protein pegylated compounds (2025-03-18),

5. 12239697 - Virus-like particle conjugates (2025-03-04),

6. 12053515 - Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F (2024-08-06),

7. 11878054 - VLP stabilized vaccine compositions (2024-01-23),

8. 11809172 - Just-in-time bioprocess plant system (2023-11-07),

9. 11389519 - Virus-like particle conjugates (2022-07-19),

10. 11376323 - Mixtures of polysaccharide protein pegylated compounds (2022-07-05),

11. 11366458 - Just-in-time bioprocess plant system (2022-06-21),

12. 11110163 - Heat stable vaccines (2021-09-07),

13. 10981129 - Double chamber device for point of use mixing (2021-04-20),

14. 10758606 - VLP stabilized vaccine compositions (2020-09-01),

15. 10751404 - Bordetella pertussis immunogenic vaccine compositions (2020-08-25),

Title: Subhash V Kapre: Innovator in Vaccine Development

Introduction: Subhash V Kapre, based in Redmond, WA, is a distinguished inventor known for his significant contributions to the field of immunology. With an impressive portfolio of 23 patents, he has dedicated his career to innovating solutions, particularly in vaccine development aimed at combating infectious diseases.

Latest Patents: One of Subhash's most notable recent inventions is centered around virus-like particle conjugates. This invention focuses on an immunogenic composition that includes conjugates and virus-like particle compositions. It aims to provide an effective vaccine and therapeutic method for preventing infections caused by Human Papillomavirus. Additionally, he has developed multivalent pneumococcal glycoconjugate vaccines that contain the newly emerging serotype 24F. This inventive work involves multivalent pneumococcal glycoconjugate compositions containing polysaccharide 24F and aims to manufacture and utilize these for immunization against multiple serotypes of pneumococcus.

Career Highlights: Throughout his career, Subhash has been affiliated with prominent organizations such as Inventprise, LLC and Serum Institute of India Pvt Ltd. His work has solidified his reputation as an innovator in the pharmaceutical industry, particularly in the area of vaccine development.

Collaborations: Subhash has had the opportunity to work alongside talented individuals, including Anup K Datta and Kapil Subhash Kapre. These collaborations have enhanced his research endeavors and contributed significantly to advancing vaccine technologies.

Conclusion: Subhash V Kapre's work exemplifies the intersection of innovation and public health. With his extensive number of patents and groundbreaking inventions, he continues to make profound impacts in the field of immunology. His dedication to developing effective vaccines not only demonstrates his expertise as an inventor but also underscores the importance of ongoing research and innovation in fighting infectious diseases.

Profile summary based on public USPTO records.